Morgan Stanley
NUVA

Morgan Stanley’s NuVasive, Inc. NUVA Stock Holding History

Morgan Stanley’s Portfolio NUVA Stock Details NUVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-670,948
Closed -$27.9M – 7770
2023
Q2 		$27.9M Sell
670,948
-340,330
-34% -$14M ﹤0.01% 2124
2023
Q1 		$41.8M Buy
1,011,278
+629,104
+165% +$26.9M ﹤0.01% 1707
2022
Q4 		$15.8M Sell
382,174
-58,996
-13% -$2.39M ﹤0.01% 2584
2022
Q3 		$19.3M Sell
441,170
-411,323
-48% -$19.9M ﹤0.01% 2220
2022
Q2 		$41.9M Buy
852,493
+295,119
+53% +$15.8M 0.01% 1518
2022
Q1 		$31.6M Buy
557,374
+172,943
+45% +$9.19M ﹤0.01% 1660
2021
Q4 		$20.2M Sell
384,431
-22,061
-5% -$1.2M ﹤0.01% 2130
2021
Q3 		$24.3M Sell
406,492
-78,960
-16% -$4.87M ﹤0.01% 1884
2021
Q2 		$32.9M Buy
485,452
+88,299
+22% +$6.03M ﹤0.01% 1655
2021
Q1 		$26M Sell
397,153
-79,379
-17% -$4.76M ﹤0.01% 1680
2020
Q4 		$26.8M Buy
476,532
+52,858
+12% +$2.6M ﹤0.01% 1552
2020
Q3 		$20.6M Buy
423,674
+178,396
+73% +$9.61M ﹤0.01% 1468
2020
Q2 		$13.7M Buy
245,278
+210,935
+614% +$12.2M ﹤0.01% 1698
2020
Q1 		$1.74M Sell
34,343
-105,350
-75% -$7.06M ﹤0.01% 3485
2019
Q4 		$10.8M Buy
139,693
+109,313
+360% +$7.72M ﹤0.01% 2356
2019
Q3 		$1.93M Sell
30,380
-34,793
-53% -$2.17M ﹤0.01% 3832
2019
Q2 		$3.82M Buy
65,173
+28,047
+76% +$1.66M ﹤0.01% 3207
2019
Q1 		$2.11M Sell
37,126
-72,901
-66% -$3.87M ﹤0.01% 3540
2018
Q4 		$5.45M Sell
110,027
-48,125
-30% -$2.89M ﹤0.01% 2808
2018
Q3 		$11.2M Sell
158,152
-33,171
-17% -$2.11M ﹤0.01% 2289
2018
Q2 		$9.97M Sell
191,323
-47,984
-20% -$2.51M ﹤0.01% 2381
2018
Q1 		$12.5M Buy
239,307
+22,543
+10% +$1.14M ﹤0.01% 2122
2017
Q4 		$12.7M Sell
216,764
-322,673
-60% -$18.3M ﹤0.01% 2156
2017
Q3 		$29.9M Buy
539,437
+417,292
+342% +$27.6M 0.01% 1256
2017
Q2 		$9.4M Sell
122,145
-80,827
-40% -$6.04M ﹤0.01% 2233
2017
Q1 		$15.2M Sell
202,972
-37,759
-16% -$2.74M ﹤0.01% 1799
2016
Q4 		$16.2M Buy
240,731
+178,585
+287% +$11.5M 0.01% 1742
2016
Q3 		$4.14M Sell
62,146
-14,166
-19% -$902K ﹤0.01% 2851
2016
Q2 		$4.56M Buy
76,312
+63,086
+477% +$3.41M ﹤0.01% 2698
2016
Q1 		$644K Sell
13,226
-95,492
-88% -$4.33M ﹤0.01% 4263
2015
Q4 		$5.88M Buy
108,718
+71,064
+189% +$3.62M ﹤0.01% 2507
2015
Q3 		$1.82M Sell
37,654
-114,395
-75% -$5.91M ﹤0.01% 3601
2015
Q2 		$7.2M Buy
152,049
+58,561
+63% +$2.74M ﹤0.01% 2444
2015
Q1 		$4.3M Sell
93,488
-26,809
-22% -$1.25M ﹤0.01% 2888
2014
Q4 		$5.67M Buy
120,297
+13,361
+12% +$557K ﹤0.01% 2609
2014
Q3 		$3.73M Sell
106,936
-36,569
-25% -$1.3M ﹤0.01% 2886
2014
Q2 		$5.1M Buy
143,505
+53,732
+60% +$1.84M ﹤0.01% 2655
2014
Q1 		$3.45M Buy
89,773
+57,334
+177% +$2.11M ﹤0.01% 2940
2013
Q4 		$1.05M Sell
32,439
-11,754
-27% -$353K ﹤0.01% 3904
2013
Q3 		$1.08M Sell
44,193
-280,173
-86% -$6.89M ﹤0.01% 3731
2013
Q2 		$8.04M Buy
+324,366
New +$7.1M ﹤0.01% 1870

Other funds holding NUVA

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

Morgan Stanley's NUVA Position: Q3 2023 in Review

Morgan Stanley sold out of NuVasive, Inc. (NUVA) in Q3 2023, closing a stake of 670,948 shares — an estimated $27.9M sold.

Morgan Stanley first reported a position in NUVA in Q2 2013 and held it in 41 quarters. The position peaked at $41.9M in Q2 2022. 2 funds tracked by Wall St. Rank hold NUVA as of Q3 2023.

  • Morgan Stanley reported no remaining NuVasive, Inc. position as of Q3 2023 after selling out during the quarter.
  • Morgan Stanley sold 670,948 NuVasive, Inc. shares in Q3 2023, an estimated $27.9M.
  • Morgan Stanley first reported a position in NuVasive, Inc. in Q2 2013 and held it in 41 quarters.
  • Morgan Stanley's NuVasive, Inc. position peaked at $41.9M in Q2 2022.
  • 2 funds tracked by Wall St. Rank held NuVasive, Inc. as of Q3 2023.

Based on Morgan Stanley's 13F filing for Q3 2023, filed 15 Nov 2023.